The apolipoprotein E knockout mouse: A model documenting accelerated atherogenesis in uremia

Journal of the American Society of Nephrology

Volumn 14, Issue 2, 2003, Pages 311-316

  Buzello, Moriz ^b   Törnig, Johannes ^b   Faulhaber, Jörg ^b   Ehmke, Heimo ^b   Ritz, Eberhard ^b   Amann, Kerstin ^a  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; TRIACYLGLYCEROL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ATHEROSCLEROSIS; ARTERIAL PRESSURE; ARTICLE; ATHEROGENESIS; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DYSLIPIDEMIA; FOAM CELL; HEART LEFT VENTRICLE; HEART WEIGHT; KIDNEY DYSFUNCTION; KNOCKOUT MOUSE; LOW FAT DIET; LYMPHOCYTE; MORPHOLOGY; MOUSE; NONHUMAN; PARTIAL NEPHRECTOMY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SMOOTH MUSCLE FIBER; TRIACYLGLYCEROL BLOOD LEVEL; UNINEPHRECTOMY; UREMIA;

EID: 0037306239     PISSN: 10466673     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ASN.0000045048.71975.FC     Document Type: Article

References (16)

1. Lindner A, Charra B, Sherrard DJ, Scribner BH: Accelerated atherosclerosis in prolonged maintenance hemodialysis. N Engl J Med 290: 697-701, 1974
2. Foley RN, Culleton BF, Parfrey PS, Harnett JD, Kent GM, Murray DC, Barre PE: Cardiac disease in diabetic end-stage renal disease. Diabetologia 40: 1307-1312, 1997
3. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL: Beyond cholesterol. Modifications of low density lipoprotein that increases its atherogenicity. N Engl J Med 320: 915-924, 1989
4. Zhang SH, Reddick RL, Piedrahita JA, Maeda N: Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science 258: 468-471, 1992
5. Nabokov AV, Amann K, Wessels S, Münter K, Wagner J, Ritz E: Endothelin receptor antagonists influence cardiovascular morphology in uremic rats. Kidney Int 55: 512-519, 1999
6. Schwarz U, Amann K, Orth SR, Simonaviciene A, Wessels S, Ritz E: Effect of 1,25 (OH) 2 vitamin D3 on glomerulosclerosis in subtotally nephrectomized rats. Kidney Int 53: 1696-1705, 1998
7. Matffeldt T, Mall G, Gharehbaghi H, Möller P: Estimation of surface area and lenght with the orientator. J Microsc 159: 301-317, 1990
8. Dono R, Texido G, Dussel R, Ehmke H, Zeller R: Impaired cerebral cortex development and blood pressure regulation in FGF-2-deficient mice. EMBO 17: 4213-4225, 1998
9. Amann K, Kronenberg G, Gehlen F, Wessels S, Orth S, Münter K, Ehmke H, Mall G, Ritz E: Cardiac remodelling in experimental renal failure-an immunhistochemical study. Nephrol Dial Transplant 13: 1958-1966, 1991
10. Barton M, Haudenschild CC, d'Uscio LV, Shaw S, Munter K, Luscher TF: Endothelin ETA receptor blockade restores NO-mediated endothelial function and inhibits atherosclerosis in apolipoprotein E-deficient mice. Proc Natl Acad Sci USA 24 14367-14372, 1998
11. Amann K, Wolf B, Nichols C, Törnig J, Schwarz U, Zeier M, Mall G, Ritz E: Aortic changes in experimental renal failure Hyperplasia or hypertrophy of smooth muscle cells? Hypertension 29: 770-775, 1997
12. Candido R, Jandeleit-Dahm KA, Cao Z, Nesteroff SP, Burns WC, Twigg SM, Dilley RJ, Cooper ME, Allen TJ: Prevention of accelerated atherosclerosis by angiotensin-converting enzyme inhibition in diabetic apolipoprotein E-deficient mice. Circulation 106: 246-253, 2002
13. Patel S, Thelander EM, Hernandez M, Montenegro J, Hassing H, Burton C, Mundt S, Hermanowski-Vosatka A, Wright SD, Chao YS, Detmers PA: ApoE(-/-) mice develop atherosclerosis in the absence of complement component C5. Biochem Biophys Res Commun 286: 170, 2001
14. Schwarz U, Buzello M, Ritz E, Stein G, Raabe G, Wiest G, Mall G, Amann K: Morphology of coronary artherosclerotic lesions in patients with end-stage renal disease. Nephrol Dial Transplant 15: 218-223, 2000
15. Nitta K, Ishizuka T, Horita S, Hayashi T, Ajiro A, Uchida K, Honda K, Oba T, Kawashima A, Yumura W, Kabaya T, Akiba T, Nihei H: Soluble osteopontin and vascular calcification in hemodialysis patients. Nephron 89: 455-458, 2001
16. Park L, Raman KG, Lee KJ, Lu Y, Ferran, Jr LJ, Chow WS, Stern D, Schmidt AM: Suppression of accelerated diabetic atherosclerosis by the soluble receptor for advanced glycation end-products. Nat Med 4: 1025-1031, 1998